These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9952265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H, Takami A, Murotani K, Numoto S, Okumura A.
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [Abstract] [Full Text] [Related]

  • 4. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B, Spencer N, Maly M, Pitterle M, Williams E, Collins M, Jones J.
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [Abstract] [Full Text] [Related]

  • 5. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC, Diener W, Kutschke G, Schneble HJ, Korinthenberg R, Sutor AH.
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [Abstract] [Full Text] [Related]

  • 6. Auditory event related potentials in patients with epilepsy on sodium valproate monotherapy.
    Panagopoulos GR, Thomaides T, Tagaris G, Karageorgiou CL.
    Acta Neurol Scand; 1997 Jul; 96(1):62-4. PubMed ID: 9262135
    [Abstract] [Full Text] [Related]

  • 7. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML, Fontana G, Lussana F, Chiesa V, Vignoli A, Canevini MP, Cattaneo M.
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [Abstract] [Full Text] [Related]

  • 8. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M, Yakinci C.
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
    Rosenfeld WE, Liao S, Kramer LD, Anderson G, Palmer M, Levy RH, Nayak RK.
    Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ.
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [Abstract] [Full Text] [Related]

  • 18. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T, Treiss I, Kohlmueller D, Mehlem P, Teich M, Longin E, Gerstner T, Koenig SA, Schulze A.
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [Abstract] [Full Text] [Related]

  • 19. Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
    Hadzagic-Catibusic F, Hasanbegovic E, Melunovic M, Zubcevic S, Uzicanin S.
    Med Arch; 2017 Aug; 71(4):239-242. PubMed ID: 28974841
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.